|Articles|March 29, 2017

Influenza B Cases Continue to Rise in the United States

Author(s)Einav Keet

Although cases of influenza A are on the decline, a late season surge in influenza B cases are helping to extend flu season across parts of the United States.

Winter is over but the same cannot be said for the 2016-2017 flu season, with the Centers for Disease Control and Prevention (CDC) expecting significant flu activity to continue in the coming weeks.

After five consecutive weeks of decreasing activity, CDC surveillance reports have noted that 36 states are still experiencing widespread flu activity. While the predominant strain of the virus continues to be influenza A (H3N2), a late season uptick in cases of influenza B infections and a decline in influenza A is helping extend the flu season into the spring months.

According to the most recent FluView report, of the flu-positive respiratory specimens collected around the country, about 53% were positive for influenza A and nearly 47% positive for influenza B for the week ending March 18, 2017. In the previous week, 61% of specimens were positive for influenza A while 39% were positive for influenza B. So far this flu season, influenza A has accounted for more than 79% of all flu-positive respiratory specimens.

Overall the percentage of respiratory specimens that tested positive for flu has declined to 18.3% from the previous week’s rate of 18.6%, though there are indicators that the virus continues to impact many parts of the country. Although nine state are now reporting low influenza-like illness (ILI) activity and 23 states are experiencing minimal ILI activity, Alabama, Georgia, Indiana, Kansas, Kentucky, Louisiana, Maryland, Minnesota, Mississippi, Oklahoma, South Carolina, and Virginia are still reporting high ILI activity.

In Alabama, state law makers recently introduced new legislation in the state senate that would require schools to provide parents with information on the flu vaccine. The new measure comes as high flu activity continues in the state during a flu season that has seen high numbers of ill students, prompting school closures. Under the new proposed bill, Alabama school officials would be required to offer information to parents about flu symptoms and virus transmission, along with information about flu vaccination, CDC immunization recommendations, and other infectious diseases.

The Oklahoma State Department of Health has reported four new flu-related deaths in its most recent week of surveillance, bringing the state’s total to 68 deaths so far this flu season. Tulsa County has experienced the highest number of influenza-related deaths in the state with a total of 18, while Oklahoma county has seen eight deaths. The majority of those deaths (47) this season occurred in adults age 65 and older. Of the four new deaths reported in the state, one was a child under the age of 4 in Cherokee County. As a result of the steady flu activity, health officials are still offering flu vaccination to anyone age 6 months or older.

In related news, a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania suggests that doctors may be able to increase the rate of flu vaccination among patients by using a technique called “active choice”. In their paper, published in the Journal of General Internal Medicine, researchers found that by notifying patients of their eligibility for the flu vaccine and prompting them to accept or decline a vaccination order, health care providers showed a 6% increase over clinics that did not use the alert system, and a 37% relative increase in vaccinations from the prior year.

“Our results indicate that this simple intervention could be an effective and scalable approach to use the design of electronic health records to increase the rate of flu vaccinations, which are estimated to prevent millions of flu cases and tens of thousands of related hospitalizations every year,” said study lead author Mitesh S. Patel, MD, MBA, MS in a recent press release. By changing the way these choices are framed, the researchers hope they can help change patient behavior and improve public health.


Related to this article

REMAP-CAP and the Tamiflu “Pre-Release”: A Set-Up for Disaster
Preliminary REMAP-CAP data suggesting oseltamivir may increase mortality in critically ill ICU influenza patients has sparked polarized reactions, but clinicians should await the full peer-reviewed manuscript before drawing broad conclusions, since the signal comes from a narrow, severely ill population and may reflect a therapeutic window effect rather than a blanket lack of efficacy.
Asymptomatic C difficile Colonization in Infants Doesn’t Mean Benign
A new study in infants challenges the long-standing belief about the pathogen’s effects in the youngest pediatric population. Senior author Joseph Zackular, PhD, provides insights around his work including how it reshapes gut development and offers potential intervention strategies to shield neonates.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.